BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26266098)

  • 21. Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.
    Kissel M; Martel-Lafay I; Lequesne J; Faivre JC; Le Péchoux C; Stefan D; Barraux V; Loiseau C; Grellard JM; Danhier S; Lerouge D; Chouaid C; Gervais R; Thariat J
    BMC Cancer; 2019 Dec; 19(1):1237. PubMed ID: 31856742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview.
    Zeng KL; Tseng CL; Soliman H; Weiss Y; Sahgal A; Myrehaug S
    Front Oncol; 2019; 9():337. PubMed ID: 31119099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.
    Conde-Moreno AJ; Lopez-Guerra JL; Macias VA; Vázquez de la Torre ML; Samper Ots P; San José-Maderuelo S; Pastor Peidro J; López-Torrecilla J; Expósito-Hernández J
    Clin Transl Oncol; 2016 Apr; 18(4):342-51. PubMed ID: 26329294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.
    Ricardi U; Badellino S; Filippi AR
    J Radiat Res; 2016 Aug; 57(S1):i58-i68. PubMed ID: 26962198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).
    Habl G; Straube C; Schiller K; Duma MN; Oechsner M; Kessel KA; Eiber M; Schwaiger M; Kübler H; Gschwend JE; Combs SE
    BMC Cancer; 2017 May; 17(1):361. PubMed ID: 28532400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland.
    Sharrett J; Pederson A
    Cureus; 2015 Dec; 7(12):e438. PubMed ID: 26858919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).
    Wong AC; Watson SP; Pitroda SP; Son CH; Das LC; Stack ME; Uppal A; Oshima G; Khodarev NN; Salama JK; Weichselbaum RR; Chmura SJ
    Cancer; 2016 Jul; 122(14):2242-50. PubMed ID: 27206146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local ablative radiotherapy of oligometastatic colorectal cancer].
    Petersen C; Gauer T
    Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A critical review on oligometastatic disease: a radiation oncologist's perspective.
    Pacifico P; Colciago RR; De Felice F; Boldrini L; Salvestrini V; Nardone V; Desideri I; Greco C; Arcangeli S
    Med Oncol; 2022 Sep; 39(12):181. PubMed ID: 36071292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
    Wujanto C; Vellayappan B; Siva S; Louie AV; Guckenberger M; Slotman BJ; Onishi H; Nagata Y; Liu M; Lo SS
    Front Oncol; 2019; 9():1219. PubMed ID: 31799188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
    Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
    Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
    Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
    Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography.
    Kneebone A; Hruby G; Ainsworth H; Byrne K; Brown C; Guo L; Guminski A; Eade T
    Eur Urol Oncol; 2018 Dec; 1(6):531-537. PubMed ID: 31158100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multinational report of technical factors on stereotactic body radiotherapy for oligometastases.
    Redmond KJ; Lo SS; Dagan R; Poon I; Foote MC; Erler D; Lee Y; Lohr F; Biswas T; Ricardi U; Sahgal A
    Future Oncol; 2017 May; 13(12):1081-1089. PubMed ID: 28152619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.
    Dellas K
    Breast Care (Basel); 2011 Oct; 6(5):363-368. PubMed ID: 22619646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.
    Tham JLM; Ng SP; Khor R; Wada M; Gan H; Thai AA; Corry J; Bahig H; Mäkitie AA; Nuyts S; De Bree R; Strojan P; Ng WT; Eisbruch A; Chow JCH; Ferlito A
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
    Milano MT; Katz AW; Muhs AG; Philip A; Buchholz DJ; Schell MC; Okunieff P
    Cancer; 2008 Feb; 112(3):650-8. PubMed ID: 18072260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic Radiotherapy for Oligometastasis.
    Otake S; Goto T
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
    Piroth MD; Krug D; Feyer P; Baumann R; Combs S; Duma MN; Dunst J; Fastner G; Fietkau R; Guckenberger M; Haase W; Harms W; Hehr T; Sedlmayer F; Souchon R; Strnad V; Budach W
    Strahlenther Onkol; 2022 Jul; 198(7):601-611. PubMed ID: 35527272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.